Influence of tacrolimus on glucose metabolism before and after renal transplantation : A prospective study
Most studies concerning the influence of tacrolimus on glucose metabolism have been performed either in animals or after organ transplantation. These clinical studies have largely been transversal with patients who were using steroids. Therefore, this prospective, longitudinal study investigated the...
Gespeichert in:
| Veröffentlicht in: | Journal of the American Society of Nephrology 2001-03, Vol.12 (3), p.583-588 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 588 |
|---|---|
| container_issue | 3 |
| container_start_page | 583 |
| container_title | Journal of the American Society of Nephrology |
| container_volume | 12 |
| creator | VAN DUIJNHOVEN, Elly M BOOTS, Johannes M. M CHRISTIAANS, Maarten H. L WOLFFENBUTTEL, Bruce H. R VAN HOOFF, Johannes P |
| description | Most studies concerning the influence of tacrolimus on glucose metabolism have been performed either in animals or after organ transplantation. These clinical studies have largely been transversal with patients who were using steroids. Therefore, this prospective, longitudinal study investigated the influence of tacrolimus on glucose metabolism before and after transplantation. Eighteen Caucasian dialysis patients underwent an intravenous glucose tolerance test before and 5 d after the start of tacrolimus. Insulin sensitivity index (k(G)), insulin resistance (insulin/glucose ratio and homeostasis model assessment), and C-peptide and insulin secretion were calculated. Trough levels of tacrolimus were measured. After transplantation, the occurrence of posttransplantation diabetes mellitus (PTDM) was prospectively monitored. Statistical analysis was performed using the Wilcoxon signed ranks test and Spearman's rho for correlation. Before tacrolimus, k(G) was indeterminate in three patients. During tacrolimus, k(G) decreased in 16 of 18 patients, from a median of 1.74 mmol/L per min to 1.08 mmol/L per min (P |
| doi_str_mv | 10.1681/ASN.V123583 |
| format | Article |
| fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1681_ASN_V123583</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>11181807</sourcerecordid><originalsourceid>FETCH-LOGICAL-c271t-e8dfe3e489512d2e70f246ec9d2e2206e02f6083a67f203a1073a9e79cd2dfcf3</originalsourceid><addsrcrecordid>eNpFkEtLAzEURoMotlZX7iXgUkbzmEky7krxUSi68LEd0uRGpsyLJCP03xvpoKv7cTn3wncQuqTklgpF75ZvL7eflPFC8SM0pwXnGc8LcpwyyUUmhOQzdBbCjhBaMClP0YxSqqgico526841I3QGcO9w1Mb3Td2OAfcd_mpG0wfALUS9TevQ4i243gPWncXaRfDYQ6cbHL3uwtDoLupYp8t7vMSD78MAJtbfgEMc7f4cnTjdBLiY5gJ9PD68r56zzevTerXcZIZJGjNQ1gGHXJUFZZaBJI7lAkyZMmNEAGFOEMW1kI4RrimRXJcgS2OZdcbxBbo5_E1dQvDgqsHXrfb7ipLq11iVjFWTsURfHehh3LZg_9lJUQKuJ0AHoxuXqpo6_HElKZSk_AeS9HS1</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Influence of tacrolimus on glucose metabolism before and after renal transplantation : A prospective study</title><source>MEDLINE</source><source>EZB Electronic Journals Library</source><creator>VAN DUIJNHOVEN, Elly M ; BOOTS, Johannes M. M ; CHRISTIAANS, Maarten H. L ; WOLFFENBUTTEL, Bruce H. R ; VAN HOOFF, Johannes P</creator><creatorcontrib>VAN DUIJNHOVEN, Elly M ; BOOTS, Johannes M. M ; CHRISTIAANS, Maarten H. L ; WOLFFENBUTTEL, Bruce H. R ; VAN HOOFF, Johannes P</creatorcontrib><description>Most studies concerning the influence of tacrolimus on glucose metabolism have been performed either in animals or after organ transplantation. These clinical studies have largely been transversal with patients who were using steroids. Therefore, this prospective, longitudinal study investigated the influence of tacrolimus on glucose metabolism before and after transplantation. Eighteen Caucasian dialysis patients underwent an intravenous glucose tolerance test before and 5 d after the start of tacrolimus. Insulin sensitivity index (k(G)), insulin resistance (insulin/glucose ratio and homeostasis model assessment), and C-peptide and insulin secretion were calculated. Trough levels of tacrolimus were measured. After transplantation, the occurrence of posttransplantation diabetes mellitus (PTDM) was prospectively monitored. Statistical analysis was performed using the Wilcoxon signed ranks test and Spearman's rho for correlation. Before tacrolimus, k(G) was indeterminate in three patients. During tacrolimus, k(G) decreased in 16 of 18 patients, from a median of 1.74 mmol/L per min to 1.08 mmol/L per min (P<0.0001). The correlation between C-peptide and insulin data was excellent. Insulin secretion decreased from 851.0 mU x min/L to 558.0 mU x min/L (P = 0.014), whereas insulin resistance did not change. Insulin sensitivity correlated negatively with tacrolimus trough level. After transplantation, three patients developed PTDM; before tacrolimus, two had an indeterminate and one a low normal k(G). During tacrolimus administration, k(G) decreased in almost all patients as a result of a diminished insulin secretion response to a glucose load, whereas insulin resistance did not change. Patients with an abnormal or indeterminate k(G) seem to be at risk of developing PTDM while on tacrolimus.</description><identifier>ISSN: 1046-6673</identifier><identifier>EISSN: 1533-3450</identifier><identifier>DOI: 10.1681/ASN.V123583</identifier><identifier>PMID: 11181807</identifier><identifier>CODEN: JASNEU</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott Williams & Wilkins</publisher><subject>Adult ; Animals ; Biological and medical sciences ; Diabetes Mellitus - etiology ; Female ; Glucose - metabolism ; Glucose Tolerance Test ; Humans ; Immunomodulators ; Immunosuppressive Agents - adverse effects ; Insulin - metabolism ; Insulin Resistance ; Insulin Secretion ; Kidney Transplantation - adverse effects ; Kidney Transplantation - physiology ; Longitudinal Studies ; Male ; Medical sciences ; Middle Aged ; Pharmacology. Drug treatments ; Prospective Studies ; Tacrolimus - adverse effects</subject><ispartof>Journal of the American Society of Nephrology, 2001-03, Vol.12 (3), p.583-588</ispartof><rights>2001 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27929,27930</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=905871$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11181807$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>VAN DUIJNHOVEN, Elly M</creatorcontrib><creatorcontrib>BOOTS, Johannes M. M</creatorcontrib><creatorcontrib>CHRISTIAANS, Maarten H. L</creatorcontrib><creatorcontrib>WOLFFENBUTTEL, Bruce H. R</creatorcontrib><creatorcontrib>VAN HOOFF, Johannes P</creatorcontrib><title>Influence of tacrolimus on glucose metabolism before and after renal transplantation : A prospective study</title><title>Journal of the American Society of Nephrology</title><addtitle>J Am Soc Nephrol</addtitle><description>Most studies concerning the influence of tacrolimus on glucose metabolism have been performed either in animals or after organ transplantation. These clinical studies have largely been transversal with patients who were using steroids. Therefore, this prospective, longitudinal study investigated the influence of tacrolimus on glucose metabolism before and after transplantation. Eighteen Caucasian dialysis patients underwent an intravenous glucose tolerance test before and 5 d after the start of tacrolimus. Insulin sensitivity index (k(G)), insulin resistance (insulin/glucose ratio and homeostasis model assessment), and C-peptide and insulin secretion were calculated. Trough levels of tacrolimus were measured. After transplantation, the occurrence of posttransplantation diabetes mellitus (PTDM) was prospectively monitored. Statistical analysis was performed using the Wilcoxon signed ranks test and Spearman's rho for correlation. Before tacrolimus, k(G) was indeterminate in three patients. During tacrolimus, k(G) decreased in 16 of 18 patients, from a median of 1.74 mmol/L per min to 1.08 mmol/L per min (P<0.0001). The correlation between C-peptide and insulin data was excellent. Insulin secretion decreased from 851.0 mU x min/L to 558.0 mU x min/L (P = 0.014), whereas insulin resistance did not change. Insulin sensitivity correlated negatively with tacrolimus trough level. After transplantation, three patients developed PTDM; before tacrolimus, two had an indeterminate and one a low normal k(G). During tacrolimus administration, k(G) decreased in almost all patients as a result of a diminished insulin secretion response to a glucose load, whereas insulin resistance did not change. Patients with an abnormal or indeterminate k(G) seem to be at risk of developing PTDM while on tacrolimus.</description><subject>Adult</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Diabetes Mellitus - etiology</subject><subject>Female</subject><subject>Glucose - metabolism</subject><subject>Glucose Tolerance Test</subject><subject>Humans</subject><subject>Immunomodulators</subject><subject>Immunosuppressive Agents - adverse effects</subject><subject>Insulin - metabolism</subject><subject>Insulin Resistance</subject><subject>Insulin Secretion</subject><subject>Kidney Transplantation - adverse effects</subject><subject>Kidney Transplantation - physiology</subject><subject>Longitudinal Studies</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Pharmacology. Drug treatments</subject><subject>Prospective Studies</subject><subject>Tacrolimus - adverse effects</subject><issn>1046-6673</issn><issn>1533-3450</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkEtLAzEURoMotlZX7iXgUkbzmEky7krxUSi68LEd0uRGpsyLJCP03xvpoKv7cTn3wncQuqTklgpF75ZvL7eflPFC8SM0pwXnGc8LcpwyyUUmhOQzdBbCjhBaMClP0YxSqqgico526841I3QGcO9w1Mb3Td2OAfcd_mpG0wfALUS9TevQ4i243gPWncXaRfDYQ6cbHL3uwtDoLupYp8t7vMSD78MAJtbfgEMc7f4cnTjdBLiY5gJ9PD68r56zzevTerXcZIZJGjNQ1gGHXJUFZZaBJI7lAkyZMmNEAGFOEMW1kI4RrimRXJcgS2OZdcbxBbo5_E1dQvDgqsHXrfb7ipLq11iVjFWTsURfHehh3LZg_9lJUQKuJ0AHoxuXqpo6_HElKZSk_AeS9HS1</recordid><startdate>20010301</startdate><enddate>20010301</enddate><creator>VAN DUIJNHOVEN, Elly M</creator><creator>BOOTS, Johannes M. M</creator><creator>CHRISTIAANS, Maarten H. L</creator><creator>WOLFFENBUTTEL, Bruce H. R</creator><creator>VAN HOOFF, Johannes P</creator><general>Lippincott Williams & Wilkins</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20010301</creationdate><title>Influence of tacrolimus on glucose metabolism before and after renal transplantation : A prospective study</title><author>VAN DUIJNHOVEN, Elly M ; BOOTS, Johannes M. M ; CHRISTIAANS, Maarten H. L ; WOLFFENBUTTEL, Bruce H. R ; VAN HOOFF, Johannes P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c271t-e8dfe3e489512d2e70f246ec9d2e2206e02f6083a67f203a1073a9e79cd2dfcf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Adult</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Diabetes Mellitus - etiology</topic><topic>Female</topic><topic>Glucose - metabolism</topic><topic>Glucose Tolerance Test</topic><topic>Humans</topic><topic>Immunomodulators</topic><topic>Immunosuppressive Agents - adverse effects</topic><topic>Insulin - metabolism</topic><topic>Insulin Resistance</topic><topic>Insulin Secretion</topic><topic>Kidney Transplantation - adverse effects</topic><topic>Kidney Transplantation - physiology</topic><topic>Longitudinal Studies</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Pharmacology. Drug treatments</topic><topic>Prospective Studies</topic><topic>Tacrolimus - adverse effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>VAN DUIJNHOVEN, Elly M</creatorcontrib><creatorcontrib>BOOTS, Johannes M. M</creatorcontrib><creatorcontrib>CHRISTIAANS, Maarten H. L</creatorcontrib><creatorcontrib>WOLFFENBUTTEL, Bruce H. R</creatorcontrib><creatorcontrib>VAN HOOFF, Johannes P</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Journal of the American Society of Nephrology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>VAN DUIJNHOVEN, Elly M</au><au>BOOTS, Johannes M. M</au><au>CHRISTIAANS, Maarten H. L</au><au>WOLFFENBUTTEL, Bruce H. R</au><au>VAN HOOFF, Johannes P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Influence of tacrolimus on glucose metabolism before and after renal transplantation : A prospective study</atitle><jtitle>Journal of the American Society of Nephrology</jtitle><addtitle>J Am Soc Nephrol</addtitle><date>2001-03-01</date><risdate>2001</risdate><volume>12</volume><issue>3</issue><spage>583</spage><epage>588</epage><pages>583-588</pages><issn>1046-6673</issn><eissn>1533-3450</eissn><coden>JASNEU</coden><abstract>Most studies concerning the influence of tacrolimus on glucose metabolism have been performed either in animals or after organ transplantation. These clinical studies have largely been transversal with patients who were using steroids. Therefore, this prospective, longitudinal study investigated the influence of tacrolimus on glucose metabolism before and after transplantation. Eighteen Caucasian dialysis patients underwent an intravenous glucose tolerance test before and 5 d after the start of tacrolimus. Insulin sensitivity index (k(G)), insulin resistance (insulin/glucose ratio and homeostasis model assessment), and C-peptide and insulin secretion were calculated. Trough levels of tacrolimus were measured. After transplantation, the occurrence of posttransplantation diabetes mellitus (PTDM) was prospectively monitored. Statistical analysis was performed using the Wilcoxon signed ranks test and Spearman's rho for correlation. Before tacrolimus, k(G) was indeterminate in three patients. During tacrolimus, k(G) decreased in 16 of 18 patients, from a median of 1.74 mmol/L per min to 1.08 mmol/L per min (P<0.0001). The correlation between C-peptide and insulin data was excellent. Insulin secretion decreased from 851.0 mU x min/L to 558.0 mU x min/L (P = 0.014), whereas insulin resistance did not change. Insulin sensitivity correlated negatively with tacrolimus trough level. After transplantation, three patients developed PTDM; before tacrolimus, two had an indeterminate and one a low normal k(G). During tacrolimus administration, k(G) decreased in almost all patients as a result of a diminished insulin secretion response to a glucose load, whereas insulin resistance did not change. Patients with an abnormal or indeterminate k(G) seem to be at risk of developing PTDM while on tacrolimus.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott Williams & Wilkins</pub><pmid>11181807</pmid><doi>10.1681/ASN.V123583</doi><tpages>6</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1046-6673 |
| ispartof | Journal of the American Society of Nephrology, 2001-03, Vol.12 (3), p.583-588 |
| issn | 1046-6673 1533-3450 |
| language | eng |
| recordid | cdi_crossref_primary_10_1681_ASN_V123583 |
| source | MEDLINE; EZB Electronic Journals Library |
| subjects | Adult Animals Biological and medical sciences Diabetes Mellitus - etiology Female Glucose - metabolism Glucose Tolerance Test Humans Immunomodulators Immunosuppressive Agents - adverse effects Insulin - metabolism Insulin Resistance Insulin Secretion Kidney Transplantation - adverse effects Kidney Transplantation - physiology Longitudinal Studies Male Medical sciences Middle Aged Pharmacology. Drug treatments Prospective Studies Tacrolimus - adverse effects |
| title | Influence of tacrolimus on glucose metabolism before and after renal transplantation : A prospective study |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-13T20%3A29%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Influence%20of%20tacrolimus%20on%20glucose%20metabolism%20before%20and%20after%20renal%20transplantation%20:%20A%20prospective%20study&rft.jtitle=Journal%20of%20the%20American%20Society%20of%20Nephrology&rft.au=VAN%20DUIJNHOVEN,%20Elly%20M&rft.date=2001-03-01&rft.volume=12&rft.issue=3&rft.spage=583&rft.epage=588&rft.pages=583-588&rft.issn=1046-6673&rft.eissn=1533-3450&rft.coden=JASNEU&rft_id=info:doi/10.1681/ASN.V123583&rft_dat=%3Cpubmed_cross%3E11181807%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/11181807&rfr_iscdi=true |